- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.35 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.2: 28 residues within 4Å:- Chain A: H.14, K.18, S.19, F.20, N.21, S.23, P.105, L.106, Y.107, W.108, F.109, T.150, T.151, G.152, G.153, Y.158, P.195, E.196, E.200, R.203, K.204, V.207
- Chain B: V.67, N.69, Y.70, G.71, D.120
- Ligands: 1PQ.3
25 PLIP interactions:23 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:Y.107, A:Y.107, A:Y.107, B:Y.70
- Hydrogen bonds: A:F.20, A:N.21, A:N.21, A:S.23, A:L.106, A:L.106, A:W.108, A:F.109, A:T.150, A:G.152, A:G.153, A:Y.158, A:E.196, A:R.203, B:N.69
- Water bridges: A:H.14, A:H.14, A:N.164
- Salt bridges: A:H.14
- pi-Stacking: A:F.20, A:F.20
FAD.7: 28 residues within 4Å:- Chain A: V.67, N.69, Y.70, G.71, D.120
- Chain B: H.14, K.18, S.19, F.20, N.21, S.23, P.105, L.106, Y.107, W.108, F.109, T.150, T.151, G.152, G.153, Y.158, P.195, E.196, E.200, R.203, K.204, V.207
- Ligands: 1PQ.4
23 PLIP interactions:21 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:Y.107, B:Y.107, B:Y.107, A:Y.70
- Hydrogen bonds: B:F.20, B:N.21, B:N.21, B:S.23, B:L.106, B:W.108, B:F.109, B:T.150, B:T.150, B:T.151, B:G.152, B:G.153, B:Y.158, B:E.196, A:N.69
- Water bridges: B:H.14, B:H.14, B:N.164
- Salt bridges: B:H.14
- 2 x 1PQ: (4S)-N~4~-(6-methoxyquinolin-8-yl)pentane-1,4-diamine(Non-covalent)
1PQ.3: 12 residues within 4Å:- Chain A: W.108, F.109, G.152, G.153, M.157, Y.158, N.164
- Chain B: F.129, I.131, G.177, F.181
- Ligands: FAD.2
7 PLIP interactions:3 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:I.131, B:F.181, A:W.108, A:F.109
- pi-Stacking: B:F.181
- Water bridges: A:Y.158, A:N.164
1PQ.4: 12 residues within 4Å:- Chain A: F.129, Y.135, G.177, F.181
- Chain B: W.108, F.109, G.152, G.153, Y.158, N.164, E.196
- Ligands: FAD.7
7 PLIP interactions:5 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:W.108, B:F.109, A:F.181
- Hydrogen bonds: B:E.196
- Water bridges: B:Y.158, B:N.164
- pi-Stacking: A:F.181
- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.5: 2 residues within 4Å:- Chain B: D.166, R.168
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:D.166
- Water bridges: B:S.167
GOL.8: 6 residues within 4Å:- Chain B: E.50, K.56, D.57, A.84, D.86, R.121
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:D.86, B:R.121
- Water bridges: B:T.54
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Leung, K.K. et al., Crystal structures of quinone reductase 2 bound to antimalarial drugs reveal conformational change upon reduction. J.Biol.Chem. (2013)
- Release Date
- 2013-03-13
- Peptides
- Ribosyldihydronicotinamide dehydrogenase [quinone]: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.35 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x 1PQ: (4S)-N~4~-(6-methoxyquinolin-8-yl)pentane-1,4-diamine(Non-covalent)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Leung, K.K. et al., Crystal structures of quinone reductase 2 bound to antimalarial drugs reveal conformational change upon reduction. J.Biol.Chem. (2013)
- Release Date
- 2013-03-13
- Peptides
- Ribosyldihydronicotinamide dehydrogenase [quinone]: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B